醫學院

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 33%
3. Population 27%
4. Meta-Analysis 26%
5. Cohort Studies 26%
6. Therapeutics 25%
7. Apoptosis 25%
8. Stroke 23%
9. Confidence Intervals 22%
10. Proteins 18%
11. Systematic Reviews 17%
12. Genes 16%
13. Odds Ratio 15%
14. Randomized Controlled Trials 15%
15. Hepatocellular Carcinoma 15%
16. Mortality 14%
17. Wounds and Injuries 14%
18. Neoplasm Metastasis 14%
19. Lung 14%
20. Breast Neoplasms 13%
21. In Vitro Techniques 13%
22. Arsenic 13%
23. Chronic Renal Insufficiency 13%
24. Colorectal Neoplasms 13%
25. Databases 12%
26. Inflammation 12%
27. Kidney 12%
28. Down-Regulation 12%
29. Growth 12%
30. Autophagy 12%
31. Reactive Oxygen Species 12%
32. Serum 12%
33. Lipopolysaccharides 11%
34. Incidence 11%
35. Pharmaceutical Preparations 11%
36. Survival 10%
37. Lung Neoplasms 10%
38. National Health Programs 10%
39. Phosphorylation 10%
40. Endothelial Cells 10%
41. Biomarkers 10%
42. Macrophages 10%
43. Blood Platelets 10%
44. Brain 10%
45. Gene Expression 10%
46. Atrial Fibrillation 10%
47. Oxidative Stress 9%
48. MicroRNAs 9%
49. Up-Regulation 9%
50. Nitric Oxide 9%
51. Glioblastoma 9%
52. Cardiac Myocytes 9%
53. Liver 9%
54. Carcinoma 9%
55. Prostatic Neoplasms 8%
56. Retrospective Studies 8%
57. Nanoparticles 8%
58. Bipolar Disorder 8%
59. Messenger RNA 8%
60. Elderly 8%
61. Renal Dialysis 8%
62. Cell Proliferation 8%
63. Child 8%
64. Antioxidants 8%
65. Pulmonary Veins 8%
66. Glucose 8%
67. Cytokines 8%
68. Traumatic Brain Injury 8%
69. Recurrence 8%
70. Mesenchymal Stem Cells 7%
71. ErbB Receptors 7%
72. Infections 7%
73. Cell Line 7%
74. Pain 7%
75. Non-Small Cell Lung Carcinoma 7%
76. Metabolic Syndrome 7%
77. Hypertension 7%
78. Type 2 Diabetes Mellitus 7%
79. Cell Movement 7%
80. Exercise 7%
81. Drug Therapy 7%
82. Parkinson Disease 7%
83. Calcium 7%
84. Bone and Bones 7%
85. Skin 7%
86. Logistic Models 7%
87. Control Groups 7%
88. Blood Pressure 7%
89. Machine Learning 7%
90. Cell Death 7%
91. Safety 7%
92. Heme Oxygenase-1 7%
93. Depression 7%
94. Schizophrenia 7%
95. Case-Control Studies 6%
96. Stem Cells 6%
97. Quality of Life 6%
98. Adenocarcinoma of Lung 6%
99. Fibrosis 6%
100. Tuberculosis 6%